TGFB1 and type 1 diabetes mellitus: Moreover, delivery of microparticle formulation of RA (retinoic acid) plus TGF-β1 with the presence of islet autoantigen on the surface could induce tolerogenic DCs in PLNs, thereby preventing the progression of mid-stage autoimmunity to overt T1D [139].